文献
J-GLOBAL ID:202002255043517789
整理番号:20A1932933
ワルファリンおよびリバロキサバン抗血栓療法を最適化するための臨床エンドポイントの定量的システム薬理学モデルベース予測【JST・京大機械翻訳】
Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy
著者 (5件):
Hartmann Sonja
(1Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, University of Florida, Orlando, FL, United States)
,
Biliouris Konstantinos
(1Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, University of Florida, Orlando, FL, United States)
,
Lesko Lawrence J.
(1Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, University of Florida, Orlando, FL, United States)
,
Nowak-Gottl Ulrike
(2Thrombosis & Hemostasis Treatment Center, Institute of Clinical Chemistry, University of Schleswig-Holstein, Germany)
,
Trame Mirjam N.
(1Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics, University of Florida, Orlando, FL, United States)
資料名:
Frontiers in Pharmacology (Web)
(Frontiers in Pharmacology (Web))
巻:
11
ページ:
1041
発行年:
2020年
JST資料番号:
U7091A
ISSN:
1663-9812
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)